more_reports

PDS Biotechnology Corp.

PDSB:NASDAQ

PDS Biotechnology is a clinical stage immuno-oncology company with a growing pipeline of clinical-stage immunotherapies to treat various HPV-associated cancers, including head and neck cancer, cervical and anal cancers.

streetwise book logo Streetwise Company Fact Sheet

2024/11/8 11:27:44

(PDSB:NASDAQ)

Analyst coverage

Cantor FitzgeraldLouise Chen
B. Riley SecuritiesMayank Mamtani
Alliance Global PartnersJames Molloy
H.C. Wainwright & Co.Dr. Joseph Pantginis

Streetwise Reports Articles

10/02/2024 - View Article